| Catalog No | Product Description | CAS No. | Purity | Structural Formula |
|---|---|---|---|---|
| BP0915 |
Magnolin
Magnolin has anti-inflammatory, anti-histaminic, and antioxidative effects, it might be a naturally occurring chemoprevention and therapeutic agent capable of inhibiting cell proliferation and transformation by targeting ERK1 and ERK2. Magnolin can ameliorate the renal tubular necrosis, apoptosis, and the deterioration of renal function, it reduces the renal oxidative stress, suppresses caspase-3 activity, and increases Bcl-2 expression in vivo and in vitro.
|
31008-18-1 | 98% |
|
| SBP03694 | 51652-39-2 |
|
||
| SBP03240 | 1228964-10-0 |
|
||
| BP0342 |
Chelidonine
Chelidonine is a promising model compound for overcoming MDR and for enhancing cytotoxicity of chemotherapeutics, especially against leukaemia cells, its efficacy needs to be confirmed in animal models. Chelidonine may be a potential therapeutic agent against metastasis of invasive human cancer cells, exhibits anti‑migratory and anti‑invasive effects in MDA‑MB‑231 cells, by suppressing COL‑I‑induced integrin signaling, through inhibiting the formation of the IPP complex and subsequent down‑regulation of IPP downstream signaling molecules, such as Akt and ERK1/2. Chelidonine is an alkaloid fundamental parent, a benzophenanthridine alkaloid and an alkaloid antibiotic.
|
476-32-4 | 98% |
|
| SBP02243 | 1616080-84-2 |
|
||
| BP1143 | 154-60-9 |
|
||
| BP4636 |
N-trans-Sinapoyltyramine
N-trans-sinapoyltyramine is a N-sinapoyltyramine in which the double bond adopts trans-configuration. It is a natural product found in several plant species including Piper boehmeriaefolium. It has a role as a plant metabolite. It is functionally related to a trans-sinapic acid.
|
200125-11-7 | 98% |
|
| BP0820 |
Kaempferol
1. Kaempferol activates LXR-β and suppresses SREBP-1 to enhance symptoms in metabolic syndrome. 2. Kaempferol exerts a potent inhibitory effect on in vitro bone resorption. 3. Kaempferol has anti-inflammatory action, can prevent and treat inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis. 4. Kaempferol has therapeutic potential for the prevention and treatment of thrombovascular diseases, can enhance relaxations caused by endothelium-derived and exogenous NO as well as those due to endothelium-dependent hyperpolarization. 5. Kaempferol can inhibit cancer cell invasion through blocking the PKCδ/MAPK/AP-1 cascade and subsequent MMP-9 expression and its activity, may act as a therapeutic potential candidate for cancer metastasis. 6. Kaempferol is an autophagic enhancer, has a more general protection in Parkinson's disease, can mediate antiapoptotic and antioxidant effects is the enhancement of mitochondrial turnover by autophagy. Kaempferol is a tetrahydroxyflavone in which the four hydroxy groups are located at positions 3, 5, 7 and 4'. Acting as an antioxidant by reducing oxidative stress, it is currently under consideration as a possible cancer treatment. It has a role as a geroprotector, an antibacterial agent, a plant metabolite, a human xenobiotic metabolite, a human urinary metabolite and a human blood serum metabolite. It is a member of flavonols, a tetrahydroxyflavone and a 7-hydroxyflavonol.
|
520-18-3 | 98% |
|
| SBP03758 | 823182-23-6 |
|
||
| BP3134 | 111254-18-3 |
|
||
| BP1723 | 77988-07-9 |
|
||
| SBP03923 | 117421-22-4 |
|
||
| BP3288 |
O-Methylbroussochalcone B, 4'
4'-O-methylbavachalcone is a member if the class of chalcones that is trans-chalcone substituted by a prenyl group at position 5', a hydroxy group at position 2' and methoxy groups at positions 4' and 4 respectively. It has a role as a plant metabolite. It is a member of chalcones, a member of phenols and an aromatic ether.
|
20784-60-5 | 98% |
|
| BP3006 |
1-(3,4-dimethoxyphenyl)-2-(4-allly-2,6-dimethoxyphenoxy)propan-1-ol
2-(4-Allyl-2,6-dimethoxyphenoxy)-1-(4-hydroxy-3-methoxyphenyl)-1-propanol is a phenylpropanoid.
|
41535-95-9 | 98% |
|
| SBP04168 | 143236-02-6 |
|
||
| SBP04300 | 412029-03-9 |
|
||
| BP0123 |
Actein
Actein is a triterpenoid. It has a role as a metabolite.
Actein has a stimulatory effect on osteoblastic bone formation or has potential activity against osteoporosis, it also can prevent oxidative damage to osteoblasts in osteoporotic patients. Actein's ability to pathways involved in lipid disorders and carcinogenesis may make it a new agent for preventing and treating these major disorders, it has been shown to inhibit the proliferation of human breast cancer cells, by altering the activity of the ER IP3 receptor and Na,K-ATPase, inducing calcium release and modulating the NF-κB and MEK pathways.
Actein is a triterpenoid glycoside isolated from the rhizome of Cimicifuga foetida, which has the effect of inhibiting cancer cells. Actein inhibits cell proliferation, induces autophagy and apoptosis by promoting ROS/JNK activation and inactivating AKT pathway in bladder cancer. Actein has almost no toxicity in the body
|
18642-44-9 | 98% |
|
| BP0483 |
Deoxyarbutin
Deoxyarbutin possesses a potent ability in skin lightening and antioxidation with less melanosome cytotoxicity, it is an effective hypopigmentation agent, it is widely used in skin lighting. Deoxyarbutin can combate tumour in vitro and in vivo by inhibiting the proliferation and metastasis of tumour via a p38-mediated mitochondria associated apoptotic pathway.
|
53936-56-4 | 98% |
|
| BP3124 | 41997-41-5 |
|
||
| SBP02554 | 178764-92-6 |
|
Shenshuai
Wenjing
Hedandan